Skip to content

Abnormal Fundus Pigmentation C4703439

Published: July 22, 2026Updated: August 20, 2026

Unusual coloring or dark spots observed in the back of the eye during examination. It can result from various causes including inflammation, aging, or genetic conditions and warrants further eye examination.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
H53.9
ICD-11
9A00.0
Body system
ophthalmologic
Severity
mild
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Sudden vision loss

Rapid and significant loss of vision that occurs unexpectedly, potentially indicating serious retinal damage.

This is a medical emergency - seek immediate ophthalmologic care

!

Eye pain with movement

Pain or discomfort in the eye that worsens with eye movement, suggesting optic nerve involvement.

Seek urgent ophthalmologic evaluation if eye pain is severe or persistent

Dark spots in vision

(ophthalmologic)

Presence of dark or black spots in the visual field that may float or remain stationary.

Frequency: 70-80% of patients

Blurred vision

(ophthalmologic)

Vision appears unfocused or hazy, making it difficult to see details clearly.

Frequency: 75-85% of patients

Reduced visual acuity

(ophthalmologic)

Decreased sharpness of vision that cannot be fully corrected with glasses or contact lenses.

Frequency: 50-60% of patients

Difficulty with night vision

(ophthalmologic)

Trouble seeing in low-light conditions or darkness, often described as nyctalopia.

Frequency: 45-55% of patients

Visual field defects

(ophthalmologic)

Loss of portions of the visual field, appearing as blind spots or tunnel vision.

Frequency: 40-50% of patients

Eye floaters

(ophthalmologic)

Small specks or cobweb-like shapes that drift across the field of vision.

Frequency: 35-45% of patients

Photopsia

(ophthalmologic)

Perception of flashing lights or sparks in the visual field, often indicating retinal irritation.

Frequency: 15-25% of patients

Metamorphopsia

(ophthalmologic)

Distorted vision where straight lines appear wavy or bent, affecting spatial perception.

Frequency: 10-20% of patients

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Behavioral and nutritional therapy

Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.

lifestyle
2

Regular ophthalmologic surveillance

Periodic eye examinations with detailed fundus photography to track any changes in pigmentation patterns over time. Early detection of progression allows for timely intervention if needed.

monitoring
3

UV eye protection

Daily use of quality sunglasses with UV400 protection and wide-brimmed hats to minimize oxidative stress on retinal tissues. This preventive measure helps reduce potential exacerbation of pigmentation abnormalities.

lifestyle

Additional treatment options

Antioxidant supplementation consultation

Assessment for potential benefit from antioxidant nutrients that may support ocular health. Supplementation decisions should be based on individual nutritional status and clinical findings.

medication

Fundus autofluorescence imaging

Advanced imaging technique that captures lipofuscin distribution patterns in the retina, providing additional diagnostic information about the nature of pigmentation changes. Useful for distinguishing benign from concerning findings.

procedure

Lutein and zeaxanthin supplementation

Dietary carotenoids that accumulate in the macula and may support retinal health. These compounds are natural pigments that provide protective benefits to photoreceptor cells.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Abnormal Fundus Pigmentation C4703439?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

American Academy of Ophthalmology Preferred Practice Pattern Panel. Age-Related Macular Degeneration PPP. American Academy of Ophthalmology; 2023.

guideline2023View source →
2

Kashani AH, Chen CL, Ghoraba J, et al. Fundus Pigmentary Changes in Age-Related Macular Degeneration: A Review. Progress in Retinal and Eye Research. 2022;89:101037.

review2022View source →
3

Royal College of Ophthalmologists. Age-Related Macular Degeneration: Guidelines for Management. RCOphth; 2022.

guideline2022View source →
4

Spaide RF, Chee SY, Balaratnasingam C, et al. Retinal Pigment Epithelium Abnormalities: Classification and Clinical Manifestations. Ophthalmology Retina. 2021;5(8):750-768.

review2021View source →
5

Ryan SJ, Schachat AP, Wilkinson CP, eds. Retina: Expert Consult. 6th ed. Elsevier; 2023.

textbook2023
6

Wang J, Xi X, Liu Y, et al. Fundus Pigmentary Changes in Inherited Retinal Diseases: A Systematic Review and Meta-Analysis. JAMA Ophthalmology. 2020;138(9):923-934.

meta_analysis2020View source →
7

American Academy of Ophthalmology. Screening for Retinal Pigment Epithelium Abnormalities. AAO Position Statement 2021.

position_statement2021View source →
8

Chakravarthy U, Harding SP, Rogers CA, et al. Ranibizumab versus Bevacizumab for Neovascular Age-Related Macular Degeneration: The IVAN Trial. Ophthalmology. 2019;126(8):1151-1165.

clinical_trial2019View source →
9

International Society for Genetic Eye Diseases and Retina International. Consensus Guidelines for Classification of Inherited Retinal Dystrophies with Fundus Pigmentation Abnormalities. Ophthalmic Genetics. 2019;40(3):215-228.

consensus2019View source →
10

National Eye Institute. Age-Related Macular Degeneration (AMD) Data and Statistics. NEI; 2023.

Medication Comparisons

Compare medications used to treat Abnormal Fundus Pigmentation C4703439. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy